- Blue Faery Recognizes Excellence in Liver Cancer Research
(April 8, 2025) $25,000 Grant Awarded to Support Innovative Hepatocellular Carcinoma Studies - Marquis Who's Who Honors Jane Brandman, MS, for Expertise in Health Care
(April 8, 2025) Jane Brandman, MS, is a leader making a mark on the pharmaceutical industry - Marquis Who's Who Honors Shirnett K. Williamson, MD, DABR, CFD, for Excellence in Health Care
(April 7, 2025) Shirnett K. Williamson, MD, DABR, CFD, is a renowned professional in the health care industry specializing in radiation oncology - Kathrin Dvir, MD, MS, for Recognized by Marquis Who's Who
(April 4, 2025) Kathrin Dvir, MD, MS, is a distinguished medical professional with nearly 20 years of experience, who is passionate about raising awareness for inflammatory breast cancer - Central Coast VNA & Hospice: The Best Home Health Care Provider in Monterey, CA, Expands Services to Meet Growing Community Needs
(April 4, 2025) Enhanced care programs include advance care planning, palliative care, specialty programs, and comprehensive home health services to support local families. - Texas Radiotherapy™ Introduces Breast Associates of Texas™
(April 2, 2025) Dr. Amelia Tower, Breast Surgical Oncologist, Joins Breast Associates of Texas - Marquis Who's Who Honors Aidnag Z. Diaz, MD, MPH, for Expertise in Health Care
(April 2, 2025) Aidnag Z. Diaz, MD, MPH, is celebrating 30 years of dedicated service in the health care industry - Creative Biolabs Advances Non-IgG Antibody Solutions for Immune System Research
(April 1, 2025) Creative Biolabs recently announced the services for non-IgG antibody production and purification, covering the three major types: IgE, IgM, and IgA. - Marquis Who's Who Honors Farah Zeba Zia, MD, for Expertise in Health Care
(March 31, 2025) Farah Zeba Zia, MD, is lauded for her work in women's cancer and integrative health at the National Cancer Institute - Marquis Who's Who Honors Mai H. Johnson, PhD, for Expertise in Medical Research
(March 31, 2025) Mai H. Johnson, PhD, is a distinguished expert in cancer research and therapeutic development with 25 years of dedicated service in the medical industry - Join Craig, Kelley & Faultless in Fighting for a Cure
(March 25, 2025) - Author and Chaplain Robert Marshall Introduces the Release of His New Book "I've Got This: A Love Story"
(March 24, 2025) Mildred Marshall shares her powerful journey of faith and resilience through her own words! - Marquis Who's Who Honors David C. Aguilar, PhD, for Excellence in Pharmacology
(March 24, 2025) David C. Aguilar, PhD, serves as the chief operating officer at SOHM Inc. - SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
(March 19, 2025) We will present preclinical data on targeting innate inflammation to prevent pancreatic cancer recurrence, improve complete response and survival rate in chemotherapy-treated mice, and overcome cancer resistance in those treated with immunotherapy. - March 2025 Edition of RCM Connections Explores the Power of Professional Partnerships in RCM
(March 17, 2025) Featuring Tom "Big Kahuna" McCormick and Tony DiLuca - Gary D. Stoner, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
(March 14, 2025) Gary D. Stoner, PhD, has been endorsed by Marquis Who's Who as a leader in higher education and research - Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary
(March 13, 2025) A milestone achievement in botanical therapeutics - ADAP Advocacy Releases New Policy Paper on 340B Drug Pricing Program
(March 12, 2025) Is the 340B Drug Pricing Program the Next 'Too Big to Fail'? - ADAP Advocacy Releases Supplemental Report on 340B Covered Entities
(March 4, 2025) The 340B Drug Pricing Program and Its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities - Metabolic shift in liver cancer: how PDHX acetylation drives tumor growth
(March 4, 2025) Metabolic shift in liver cancer: how PDHX acetylation drives tumor growth - Unlocking a new path to AML treatment: targeting the JMJD1C-RUNX1 axis for leukemia progression control
(March 4, 2025) Unlocking a new path to AML treatment: targeting the JMJD1C-RUNX1 axis for leukemia progression control - Targeting ER dynamics: a novel strategy for antitumor immunity
(March 4, 2025) Targeting ER dynamics: a novel strategy for antitumor immunity - Body Routers Fitness Joins the Fight for Lung Health at the Fight For Air Climb Miami on March 9
(March 3, 2025) - Andarix Pharmaceuticals CEO to Chair Radiopharmaceutical Conference
(February 27, 2025) Targeted Radiotherapies: A New Approach to Treating Cancer - Marquis Who's Who Honors Behzad Amoozgar, MD, MPH, for Contributions to Cancer Research
(February 26, 2025) Behzad Amoozgar has earned a distinguished reputation as a pioneering expert in Hematology-Oncology, Bone Marrow Transplant, and Cellular Therapy - Marquis Who's Who Honors Hengbo Zhou for Expertise in Science and Technology
(February 21, 2025) Hengbo Zhou serves as a senior scientist of Arnatar Therapeutics - Creative Biolabs Conjugation Technology: Antibody Targeting Carriers Driving Precision Drug Delivery
(February 18, 2025) Creative Biolabs leads in precision drug delivery with its unique antibody-targeting carriers and innovative conjugation technology. - Karim A. Touijer, MD, MPH, Celebrated for Expertise in Health Care as a Physician
(February 17, 2025) Karim A. Touijer, MD, MPH, is a distinguished expert in urologic oncology with over 20 years of professional success - Marquis Who's Who Honors Tanmay Abhay Kulkarni, PhD, for Expertise in Cancer Research and Higher Education
(February 13, 2025) Tanmay Abhay Kulkarni, PhD, is lauded as a seasoned researcher and assistant professor at the Mayo Clinic - ADAP Advocacy Files Amicus Curiae Briefs Supporting 340B Rebate Model
(February 11, 2025) Two amicus briefs offer distinctly patient-focused perspective on the importance of the rebate model to patients and why that model is so desperately needed
Friday, 17 June 2011
Cancer News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment